DUX4 expression activates JNK and p38 MAP kinases in myoblasts

• Christopher M. Brennan,
• Abby S. Hill,
• Michael St. Andre,
• Xianfeng Li,
• Vijaya Madeti,
• Susanne Breitkopf,
• Seth Garren,
• Liang Xue,
• Tamara Gilbert,
• Angela Hadjipanayis,
• Mara Monetti,
• Charles P. Emerson,
• Robert Moccia,
• Jane Owens,
• Nicolas Christoforou

Affiliations

Christopher M. Brennan

Rare Disease Research Unit, Pfizer Inc., Cambridge, MA 02139, USA

Abby S. Hill

Rare Disease Research Unit, Pfizer Inc., Cambridge, MA 02139, USA

Michael St. Andre

Rare Disease Research Unit, Pfizer Inc., Cambridge, MA 02139, USA

Xianfeng Li

Rare Disease Research Unit, Pfizer Inc., Cambridge, MA 02139, USA

Vijaya Madeti

NGS Technology Center, Inflammation and Immunology Research Unit, Pfizer, Cambridge, MA 02139, USA

Susanne Breitkopf

Proteomics Technology Center, Internal Medicine Research Unit, Pfizer, Cambridge, MA 02139, USA

Seth Garren

NGS Technology Center, Inflammation and Immunology Research Unit, Pfizer, Cambridge, MA 02139, USA

Liang Xue

Machine Learning and Computational Science, Pfizer Inc., Cambridge, MA 02139, USA

Tamara Gilbert

High Content Imaging Technology Center, Internal Medicine Research Unit, Pfizer, Cambridge, MA 02139, USA

Angela Hadjipanayis

NGS Technology Center, Inflammation and Immunology Research Unit, Pfizer, Cambridge, MA 02139, USA

Mara Monetti

Proteomics Technology Center, Internal Medicine Research Unit, Pfizer, Cambridge, MA 02139, USA

Charles P. Emerson

Rare Disease Research Unit, Pfizer Inc., Cambridge, MA 02139, USA

Robert Moccia

Rare Disease Research Unit, Pfizer Inc., Cambridge, MA 02139, USA

Jane Owens

Rare Disease Research Unit, Pfizer Inc., Cambridge, MA 02139, USA

Nicolas Christoforou

Rare Disease Research Unit, Pfizer Inc., Cambridge, MA 02139, USA